Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.

NCT00407784 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT00407784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aldosterone-Renin Ratio to Diagnose Primary Aldosteronism in a Population of Patients With Therapy-Resistant Hypertension: Test Characteristics, Diagnostic Value and Predictive Value for Antihypertensive Treatment. The Dutch ARRAT Study.
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2007
Completion date
November 30, 2009
Enrollment
500
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hyperaldosteronism, hypertension